Immuron (IMRN) Liabilities and Shareholders Equity (2016 - 2025)

Immuron (IMRN) has reported Liabilities and Shareholders Equity for 10 consecutive years, with $100926.2 the latest figure, recorded in Q3 2025.

• Quarterly Liabilities and Shareholders Equity fell 35.1% year-over-year to $100926.2 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $16.0 million (down 40.29% YoY) and the FY2025 annual result came in at $100926.2, down 35.1% from the prior year.
• Liabilities and Shareholders Equity declined to $100926.2 in Q3 2025 per IMRN's latest filing, from $7.2 million in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for IMRN reached as high as $19.1 million in Q2 2021 and fell as low as $100926.2 in Q3 2025.
• A 5-year average of $10.0 million and a median of $11.0 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity surged 9694.52% — and 2023, when it tumbled 99.2%.
• Year by year, Liabilities and Shareholders Equity stood at $179220.6 in 2021, then jumped by 9694.52% to $17.6 million in 2022, then slumped by 99.2% to $140416.6 in 2023, then soared by 6020.77% to $8.6 million in 2024, then plunged by 98.83% to $100926.2 in 2025.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $100926.2, $7.2 million, and $8.6 million for Q3 2025, Q2 2025, and Q4 2024 respectively.